Replies to post #7156 on $Amazing $Biotech & $olid $Microcap $tocks

[ash111]

Laden $YTEN expecting positive news when the company details its work with its C3004 trait in the coming weeks. Given the potential for significant royalty/license payments in future years, we are maintaining our Buy rating and 12-month $7.00 price.

— dough (@semodough) August 13, 2018

[ash111]

$YTEN “This technology represents a transformative application of genome editing for agriculture to improve human health,” “We are proud to partner with stakeholders throughout the biomedical and agriculture communities to help deliver responsible solutions for our planet.” https://www.agribusinessglobal.com/agrichemicals/yield10-bioscience-signs-research-license-agreement-the-broad-institute-and-pioneer/